These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5629284)

  • 41. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
    Ceccon ME; Diniz EM; Ramos JL; Vaz FA
    Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [On the value of exchange transfusion in prevention of neurologic sequelae of hemolytic disease of the newborn].
    Patrizi GF; Maggiora Vergano T; Lena G
    Arch Ital Pediatr Pueric; 1967; 25(2):93-100. PubMed ID: 5630245
    [No Abstract]   [Full Text] [Related]  

  • 43. [Study of the amniotic fluid in a severe case of hemolytic disease of the newborn: trial therapy by intra-uterine exchange transfusion].
    Mellone O; Sawaya C
    Rev Hosp Clin Fac Med Sao Paulo; 1965 Sep; 20(5):258-63. PubMed ID: 5852756
    [No Abstract]   [Full Text] [Related]  

  • 44. Hemolytic disease of the newborn in Rh(D) positive mothers.
    Gupte SC; Merchant RH; Joshi SR; Bhatia HM
    Indian Pediatr; 1983 Aug; 20(8):577-81. PubMed ID: 6420337
    [No Abstract]   [Full Text] [Related]  

  • 45. [Heinz body formation in erythrocytes of the newborn. I. In vitro studies on experimental conditions and on the effect of exchange transfusions].
    Kleihauer E; Bernau A; Betke K; Keller M; Kohne E; Riegel K
    Acta Haematol; 1970; 43(6):333-47. PubMed ID: 4991320
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. I. Somatic findings].
    Olbrich G
    Padiatr Grenzgeb; 1970; 9(3):157-61. PubMed ID: 5534905
    [No Abstract]   [Full Text] [Related]  

  • 47. [Indications for exchange transfusion independent of the bilirubin levels in the newborn with hemolytic diseases].
    de Almeida JM
    Rev Port Pediatr Pueric; 1969; 32(3):77-86. PubMed ID: 5817830
    [No Abstract]   [Full Text] [Related]  

  • 48. [Neonatal jaundice in the premature infant. Bilirubinemic level and indications for exchange transfusion].
    Cadorini S
    Minerva Pediatr; 1968 Sep; 20(38):1945-52. PubMed ID: 5754458
    [No Abstract]   [Full Text] [Related]  

  • 49. [Case of Rh incompatibility surviving after exchange transfusion].
    Matsuyama S; Morikawa N; Shibata J; Seto C; Hayashi A
    Iryo; 1966 Jan; 20(1):92-4. PubMed ID: 5949835
    [No Abstract]   [Full Text] [Related]  

  • 50. [Neuropsychiatric sapect of the development of hemolytic disease of the newborn treated by exsanguinotransfusion in school-age children].
    Degossely M; Demaret A; Duchesne-Bauduin A; Herzet JP; Dongier M; Andre A; Bouillenne JC; Brocteur J; Otto-Servais M
    Bull Soc R Belge Gynecol Obstet; 1967; 37(1):69-72. PubMed ID: 5628952
    [No Abstract]   [Full Text] [Related]  

  • 51. [Changes in 6-phosphogluconate dehydrogenase activity of erythrocytes at various periods of childhood and in hemolytic disease of the newborn].
    Kovalev IuR
    Vopr Okhr Materin Det; 1971 Mar; 16(3):87-8. PubMed ID: 5104537
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. IV. Neurologic and electroencephalographic findings].
    Müller K
    Padiatr Grenzgeb; 1970; 9(3):187-95. PubMed ID: 5534908
    [No Abstract]   [Full Text] [Related]  

  • 53. [On heparin excretion following exchange transfusions with heparinized blood].
    Vahlenkamp H; Genscher U; Künzer W
    Z Kinderheilkd; 1965 Oct; 94(1):1-11. PubMed ID: 5895526
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diagnostic and therapeutic possibilities in hemolytic disease of the newborn].
    Colucci G
    Friuli Med; 1965; 20(2):149-73. PubMed ID: 5892007
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. 3. Intellectual and psychic evaluation].
    Olbrich G
    Padiatr Grenzgeb; 1970; 9(3):176-86. PubMed ID: 5534907
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hemolytic disease in a neonate caused by rare maternal anti-erythrocyte antibodies and exchange transfusion with earlier frozen maternal blood].
    van Lingen RA; Fetter WP
    Ned Tijdschr Geneeskd; 1994 Feb; 138(9):485. PubMed ID: 8133958
    [No Abstract]   [Full Text] [Related]  

  • 57. [HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY ISOIMMUNIZATION WITH ANTI-'C(HR')].
    CALKOVSKA SIGIDOVA Z; MARTINKOVIC A
    Cesk Pediatr; 1963 Jul; 18():599-604. PubMed ID: 14056307
    [No Abstract]   [Full Text] [Related]  

  • 58. [Diagnostic and prognostic significance of erythrocyte adenosine triphosphatase activity changes in hemolytic disease in the newborn].
    Osipov AI
    Vopr Okhr Materin Det; 1969 Feb; 14(2):90. PubMed ID: 4241957
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. V. ORL and audiometric findings].
    Matz J
    Padiatr Grenzgeb; 1970; 9(3):196-201. PubMed ID: 5534909
    [No Abstract]   [Full Text] [Related]  

  • 60. [Detection and treatment of the hemolytic disease of the newborn. Our results].
    Lebeau JM; Huys J
    Bull Soc R Belge Gynecol Obstet; 1965; 35(5):415-21. PubMed ID: 5864256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.